-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Pro-Dex (NASDAQ:PDEX) Shares Cross Above 200 Day Moving Average of $17.27
Pro-Dex (NASDAQ:PDEX) Shares Cross Above 200 Day Moving Average of $17.27
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $17.27 and traded as high as $17.99. Pro-Dex shares last traded at $17.48, with a volume of 2,397 shares.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on Pro-Dex in a report on Wednesday, December 7th. They set a "hold" rating for the company.
Get Pro-Dex alerts:Pro-Dex Stock Performance
The firm has a market capitalization of $62.58 million, a price-to-earnings ratio of 16.81 and a beta of 0.91. The company has a fifty day moving average of $18.11 and a two-hundred day moving average of $17.27. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73.
Institutional Trading of Pro-Dex
Several hedge funds have recently added to or reduced their stakes in PDEX. Tower Research Capital LLC TRC raised its holdings in Pro-Dex by 345.6% in the 3rd quarter. Tower Research Capital LLC TRC now owns 2,687 shares of the medical instruments supplier's stock valued at $48,000 after acquiring an additional 2,084 shares in the last quarter. Renaissance Technologies LLC acquired a new position in Pro-Dex in the 2nd quarter valued at $168,000. State Street Corp raised its holdings in Pro-Dex by 5.8% in the 1st quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier's stock valued at $197,000 after acquiring an additional 650 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Pro-Dex by 59.2% in the 1st quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier's stock valued at $345,000 after acquiring an additional 7,762 shares in the last quarter. Finally, LSV Asset Management raised its holdings in Pro-Dex by 13.9% in the 1st quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier's stock valued at $588,000 after acquiring an additional 4,346 shares in the last quarter. 13.69% of the stock is owned by institutional investors and hedge funds.Pro-Dex Company Profile
(Get Rating)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Featured Articles
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- 3 Mid-Caps That Could Double in 2023
- Mullen Automotive Shares Jump After Signing New Partner
- REV Group Leads Specialty Vehicle Manufacturers Higher
- NVIDIA vs AMD: Which is better for 2023?
- Can FDA Approval Bolster DexCom, Inc.?
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $17.27 and traded as high as $17.99. Pro-Dex shares last traded at $17.48, with a volume of 2,397 shares.
在週三的交易中，Pro-Dex，Inc.(納斯達克代碼：PDEX-GET Rating)的股價突破了200日移動均線切入位17.27美元，最高交易價格為17.99美元。Pro-Dex的股票最新報17.48美元，成交量為2,397股。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
Separately, StockNews.com began coverage on Pro-Dex in a report on Wednesday, December 7th. They set a "hold" rating for the company.
另外，StockNews.com在12月7日星期三的一份報告中開始報道Pro-Dex。他們為該公司設定了“持有”評級。
Pro-Dex Stock Performance
Pro-Dex股票表現
The firm has a market capitalization of $62.58 million, a price-to-earnings ratio of 16.81 and a beta of 0.91. The company has a fifty day moving average of $18.11 and a two-hundred day moving average of $17.27. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73.
該公司市值為6258萬美元，本益比為16.81倍，貝塔係數為0.91。該公司的50日移動均線切入位在18.11美元，200日移動均線切入位在17.27美元。該公司的負債權益比率為0.41，速動比率為1.39，流動比率為2.73。
Institutional Trading of Pro-Dex
Pro-Dex的機構交易
Pro-Dex Company Profile
Pro-Dex公司簡介
(Get Rating)
(獲取評級)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Pro-Dex公司為世界各地的醫療器械原始設備製造商設計、開發、製造和銷售動力手術器械。該公司提供可高壓滅菌、電池供電和電動的多功能外科驅動程式和剃鬚刀，主要用於整形外科、胸部和顱頜面部市場。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- 3 Mid-Caps That Could Double in 2023
- Mullen Automotive Shares Jump After Signing New Partner
- REV Group Leads Specialty Vehicle Manufacturers Higher
- NVIDIA vs AMD: Which is better for 2023?
- Can FDA Approval Bolster DexCom, Inc.?
- 免費獲取StockNews.com Pro-Dex上的研究報告(PDEX)
- 2023年中型股可能翻一番
- 馬倫汽車簽署新合作夥伴後股價上漲
- REV集團引領專用車製造商走高
- NVIDIA VS AMD：2023年哪一種更好？
- FDA的批准能支持DexCom，Inc.嗎？
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
接受Pro-Dex Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Pro-Dex和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧